FDA Inspection 1297818 — Lawrence R. Lustig, MD

Lawrence R. Lustig, MD — FEI 3041605517

The FDA completed an inspection of Lawrence R. Lustig, MD on December 18, 2025 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 18, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)